PBYI260320P00002500 Option on Puma Biotechnology

An 'Out of The Money' option on Puma has a strike price that Puma Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Puma Biotechnology's 'Out of The Money' options include buying the options if you expect a big move in Puma Biotechnology's stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

Puma Biotechnology's Option Greeks for the contract ending on 2026-03-20 at a strike price of 2.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Puma Biotechnology's option greeks, its implied volatility helps estimate the risk of Puma Biotechnology stock implied by the prices of the options on Puma Biotechnology's stock.

Put options written on Puma Biotechnology grant holders of the option the right to sell a specified amount of Puma Biotechnology at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Puma Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Puma Biotechnology is like buying insurance aginst Puma Biotechnology's downside shift.

By selling Puma Biotechnology's put option, the investors signal their bearish sentiment. A short position in a put option written on Puma Biotechnology will generally make money when the underlying price is above the strike price. Therefore Puma Biotechnology's put payoff at expiration depends on where the Puma Stock price is relative to the put option strike price. The breakeven price of 1.35 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Puma Biotechnology's price. Finally, at the strike price of 2.5, the payoff chart is constant and positive.

Puma Biotechnology's option chain is a display of a range of information that helps investors for ways to trade options on Puma. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Puma. It also shows strike prices and maturity days for a Puma Biotechnology against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.